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ABSTRACT
Yong Gao
NONINVASIVE MONITORING OF CCl4 INDUCED ACUTE AND CHRONIC LIVER
DAMAGE IN RAT BY SINGLE QUANTUM AND TRIPLE QUANTUM FILTERED
23Na MAGNETIC RESONANCE IMAGING
In present study, single quantum (SQ) and triple quantum filtered (TQF) 23Na magnetic
resonance imaging (MRI) was used to monitor the severity and progression of CCl4
induced acute and chronic liver damage in rat model. SQ 23Na MRI was proposed to
measure the 23Na signal intensity (SI) of total tissue sodium ions, and TQF 23Na MRI was
proposed to measure the SI of intracellular sodium ions. In addition, shift reagent aided
23Na and 31P magnetic resonance spectroscopy (MRS) was used to measure in vivo
intracellular sodium concentration ([Na+i]), total tissue sodium concentration ([Na+t]) and
relative extracellular space (rECS) of liver in the same model.
In acute high dose CCl4 intoxication, 24 hours after single dose of CCl4 in 5ml per kg
body weight of mixture of CCl4 and oil in 1:1 ratio, SQ 23Na SI increased by 83% and
TQF 23Na SI increased by 174% compared to the baseline level. According to SR-aided
23Na and 31P MRS, [Na+i] increased by 188% and [Na+t] increased by 43%. In addition,
there was significant decrease in cellular energetic level, represented by ATP/Pi ratio.
vHistology examination showed pronounced inflammatory response in centrilobular
regions, with neutrophiles infiltration, fatty accumulation and swollen hepatocytes.
In chronic 8-week experiment, chronic damage was induced by biweekly administration
of CCl4 in a dosage of 0.5 ml per kg body weight. From week 1 to week 6, SQ 23Na SI
remained relatively constant, and then increased by 15% from week 6 to week 8. TQF
23Na SI progressively increased from week 1 to week 8, totally by 56%. Both SQ and
TQF 23Na SI showed significant difference between treated group and control at every
week. SR-aided 23Na and 31P MRS experiment showed that, at the end of 8-week CCl4
intoxication, both [Na+t] and rECS were higher than control, by 49% and 47%
respectively; however, there was no significant difference for [Na+i] between two groups.
Histology examination showed excessive deposition of extracellular matrix.
In conclusion, SQ and TQF 23Na MRI appears valuable in the functional assessment of
liver in noninvasive approach, and could be a promising diagnostic modality for liver
diseases in clinical area.
Navin Bansal, Ph.D.
Committee Chair
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1INTRODUCTION
Liver is the central organ for metabolism and detoxification in human body, which leaves
it vulnerable to various risk factors, like metabolic disorders, alcohol consumption, viral
infection or toxin exposure. Currently, liver disease is ranked the 8th most deadly disease
worldwide [1]. Because most of the liver diseases are chronic and progressive, it is
desirable to accurately monitor the progression of chronic liver disease so as to choose
and assess the appropriate therapeutic strategies, like chemotherapy, radiation therapy, or
liver transplantation [2-4].
Currently, liver biopsy is still the gold standard to detect and grade the liver disease.
However, this method has a few limitations, such as possible injury to patients as an
invasive procedure, false negative results and being not convenient for frequent
operations on patients. Therefore, it is necessary to find appropriate supplementary
techniques to noninvasively detect and monitor the progression of liver diseases.
Single quantum (SQ) and triple quantum filtered (TQF) 23Na magnetic resonance
imaging (MRI) has been proposed as a noninvasive method that allows one to
differentiate and measure the intracellular and extracellular sodium MR signal and does
not require infusion of an exogenous chemical shift reagent (SR) [5-10]. This technique
depends on the different relaxation characteristics of free/unbound extracellular Na+ and
protein-bound intracellular Na+. SQ 23Na MRI is used to acquire the signal from the total
tissue sodium, which mainly comprise the unbound extracellular Na+ for the high
concentration of Na+ in extracellular space, and TQF 23Na MRI is used to acquire the
signal from protein-bound intracellular Na+ [11]. Because sodium MR signal is closely
related to the sodium concentrations, thus, this technique could be used to monitor the
sodium concentration changes in biological systems. On the other hand, changes in
sodium concentration are always the reflection of the changes in the dynamic cellular
homeostasis, and disruption of this homeostasis can be seen in diseased states, like
ischemia or tumors [12, 13], therefore, this technique holds the promise to monitor the
severity and progression of the injury.
2This technique has been evaluated in several in vivo studies to monitor the 23Na SI
changes during tumor growth and response to chemotherapies, proved to be sensitive in
probing the relationship between sodium signal and tumor growth or necrosis [2, 14-16].
The present study was designed to evaluate the utility of SQ and TQF 23Na MRI in
assessing the rat liver injury in CCl4-induced hepatotoxic model, and at the same time,
SR-aided 23Na and 31P MRS was performed to measure the real time intracellular and
extracellular sodium concentrations in this model. Data from SR-aided experiments were
used to validate and also delineate the mechanisms behind the 23Na signal changes
measured by 23Na MRI.
3CHAPTER 1
OBJECTIVES
Aim 1: In vivo SQ and TQF 23Na MR imaging of rat liver in acute and chronic carbon
tetrachloride (CCl4) induced hepatotoxic model. Acute and chronic liver injuries were
induced by oral administration of CCl4 in rats. SQ 23Na MRI would be used to collect the
23Na signal of the total tissue Na+, and TQF 23Na MRI was expected to filter out the
signal from free or unbound Na+ and collect only the signal from the protein-bound Na+.
Hypothesis: In CCl4-induced liver injury, it was expected that cell membrane was
damaged and the permeability to ions was increased, resulting to an elevated [Na+i]. In
chronic experiment with CCl4 administration, liver fibrosis was expected with abundant
formation of extracellular fibrils, which could be monitored and interpreted as an
increased signal from protein-bound extracellular Na+ by TQF 23Na MRI. The total 23Na
signal by SQ 23MRI could also be increased for the increased extracellular space after
excessive deposition of extracellular matrix.
Aim 2: In vivo quantitation of [Na+i] and [Na+e] and monitoring of cellular energetic
status in the rat liver in acute and chronic CCl4 induced hepatotoxic model. The hyperfine
SR, TmDOTP5-, would be used to differentiate the intracellular and extracellular Na+
signals, and also measure the extracellular space with the help of 23Na MRS and 31P MRS.
The cellular energetic status during liver injury would be monitored by 31P MRS. The
concentration of ATP and intracellular pH would be calculated from the 31P MRS spectra.
Hypothesis: In liver injury by CCl4, the cellular membrane integrity could be damaged
and the membrane permeability to outside Na+ will be increased, which will elevate the
[Na+i], and it has been found the intracellular energetics would also be compromised and
the intracellular pH would be decreased.
4CHAPTER 2
BACKGROUND AND SIGNIFICANCE
2.1. CCl4 induced toxicological model in rats
CCl4 has been widely used as a solvent and cleaner in industry and household, and
currently its usage is restricted to research area because of its distinct toxicity to liver [17].
CCl4-induced liver injury in animals has been proved to be highly useful as an
experimental model to study the mechanism underlying the hepatotoxic effects, like
hepatitis and fibrosis [17].
The CCl4 induced hepatotoxicity is related to dose and duration. At high dose and short
term, acute toxicity ensues with hepatocellular necrosis and accumulation of
inflammatory cells in centrilobular regions and also significant fat droplet deposition in
hepatocytes [18]. At low dose and prolonged expose, a mixed response of liver injury
and regeneration comes afterward, often leading to fibrosis and cirrhosis in the late stage.
Currently, the most clearly illustrated mechanism underlying the CCl4 induced liver
injury has been related to the production of reactive radicals and lipid peroxidation [17,
19, 20].
In hepatocytes, CCl4 is transformed into CCl3* by cytochrome P450 in endoplasmic
reticulum. CCl3* is a free radical and can react with various biological substances, like
proteins, nucleotides and lipids. Furthermore, in the presence of oxygen, the CCl3*
radical is converted to the trichloromethyl peroxy (CCl3OO*), which is a more reactive
radical and can cause more widespread damage than CCl3*. CCl3OO* is more likely to
abstract a hydrogen from unsaturated poly fatty acids, e.g. the lipids in membrane,
resulting to lipid peroxidation with the formation of reactive aldehydes, carbonyls and
alkanes. These radicals will carry on the CCl4 hepatotoxic effects by binding to a variety
of biological molecules and disrupt their normal functions [17].
5CCl4 has been widely used in inducing liver fibrosis and cirrhosis with long term
administration in numerous studies [19, 21-24]. The underlying mechanism behind
fibrosis was proposed as a complex of inflammatory and regenerative responses [17, 23,
24]. It was found that the activation of hepatic stellate cells (HSCs), also known as
lipocytes or Ito cells, plays a key role during the long process of liver fibrosis [22, 23, 25,
26]. HSCs could be activated by a variety of growth factors and cytokines, especially the
transforming growth factor beta 1 (TGF1), which are derived from other liver cells, like
damaged hepatocytes, and activated HSCs, or infiltrating inflammatory cells in liver
parenchyma. Activation of HSCs causes the proliferation of HSCs and transformation of
HSCs to fibrogenic myofibroblasts, which can overproduce numerous extracellular
matrix proteins and result to liver fibrosis.
2.2 Sodium as a biomarker for cellular activities
In normal biological condition, there is a stable sodium concentration gradient across the
cell membrane, with an intracellular concentration of ~15 mM and an extracellular
concentration of ~140 mM. This trans-membrane gradient is maintained by the Na+/K+
pump in the cell membrane, which utilizes ATP to pump sodium ions out of the cell and
potassium ions into the cell. This Na+ gradient plays a very important role in cellular
activities, like regulating cell volume, playing a role in action potential, and is also used
to drive the transport of various nutrients and ions into or out of the cells. For instance,
intracellular pH is regulated by Na+/H+ exchanger to pump excess H+ out of the cells, and
Na+-glucose co-transporter drives the glucose into the cells.
The sodium gradient could be disrupted in many pathological conditions, where the
abnormal cellular metabolism, such as shortage of ATP availability and excessive
intracellular acid production, could increase the intracellular [Na+]. Therefore, sodium
concentration could be an indicator of cellular integrity and metabolic homeostasis [27].
It has been found that cell division and the acidic extracellular microenvironment in
malignancies are associated with an increase of intracellular Na+ concentration [28-30].
62.3 23Na magnetic resonance techniques
Because of its high tissue concentration, 100% natural abundance, and short T1, 23Na is
the second most sensitive magnetic resonance nucleus in biological tissues, with only 1H
being more sensitive. However, one difficulty with 23Na MR study is that the MR signal
from intra and extracellular sodiums are isochronous, therefore, simple spectroscopy or
imaging techniques can not differentiate the two sources of 23Na signals and monitor
either changes. To circumvent this difficulty, two approaches of paramagnetic SRs and
MQF technique have been developed to discriminate between Na+i and Na+e signals.
2.4 SR aided 23Na MR spectroscopy
SR is a negatively charged complex containing a lanthanide metal ion (Dy3+, Tm3+ or
Tb3+) which alters the resonance frequency of the cations, like Na+, to which it binds.
Because it is charged molecule, SR usually can not freely pass through the cell membrane
and can only bind to Na+e. When SR binds with Na+e, it can greatly alter the relaxation
characteristics of the Na+e so that the resonance signal from Na+e is altered, while at the
same time, the resonance signal from Na+i is not affected, which make it possible to
discriminate between the signals from intra or extra-cellular sodium ions.
A new kind of SRs, TmDOTP5- (Figure 1),
has been shown to bring improvement over
the dysprosium based SR and produce clear
resolved resonance peaks from intra and extra
Na+ with minimal interference with the animal
physiology [16, 31]. This SR has a net
negative charge at physiological pH value but
has a more favourable geometry for Na+ binding, which produces a better shift.
NN
NN
-1Na1O3P
-1Na1O3P
PO3Na1-1
PO3Na1-1
Figure 1. Structure of TmDOTP5-.
Tm3+
72.5 MQF 23Na MR spectroscopy
Another method is the MQF technique which utilizes the unique 23Na relaxation
properties to distinguish between Na+i and Na+e. 23Na has a spin quantum number I=3/2,
and four possible spin orientations and three possible single quantum transitions: one
inner transition of -1/2 to +1/2, and two outer transitions of -3/2 to -1/2 and +1/2 to +3/2,
shown in Figure 2. It was found that when the correlation time of Na+, C, is longer than
the larmor period, L-1, the two outer transitions will relax more quickly than the inner
transition [32]. These two distinct relaxation rates in certain condition for inner and outer
transitions make it possible to bring out the double quantum transitions of -3/2 to +1/2
and 1/2 to 3/2, and the triple quantum transition of -3/2 to +3/2. Because there is a high
concentration of macromolecules in intracellular space, like protein molecules, the Nai+ is
more likely to bind with macromolecules than the free unbound Nae+. Binding with
macromolecules could increase the C of Na+i, which results to two transition rates for
intracellular sodium and brings a strong MQF signals from within the cell, but virtually
none from outside of the cell.
Figure 2. Energy level diagram for 23Na (I = 3/2) showing the four possible energy
states. In the case of free Na+ ions, only SQ transitions are possible (a). When the Na+
ions are transiently bound to protein, the SQ outer transitions relax faster than the inner
transition, and DQ and TQ transitions become possible (b).
TQ
I -1/2>
I -3/2>
I 1/2>
I 3/2>
SQ outer
SQ inner
SQ outer
DQ
DQ
(a) Free Na+ (b) Protein-bound Na+
82.6. SQ and MQF 23Na MR imaging
In MRI, the three main sources of contrast in constructing an image are differences in
spin density, longitudinal relaxation time constant (T1) and transverse relaxation time
constant (T2). Compared to 1H MRI, which is usually T1 or T2 weighted, the main
problem with 23Na MRI is its relatively short T1 or T2 relaxation time in tissue, although
23Na MRI still could be acquired to be T2 weighted. Therefore, the spin density of Na+
concentration is more likely to be utilized to construct 23Na image. Because changes in
[Na+] is closely related to cellular activities, so 23Na MRI can yield specific functional
imaging.
The potential of TQF technique to mainly collect signal from intracellular Na+ has
stimulated the research on TQF imaging in phantom and animal studies [5, 8, 9, 33].
Various TQF imaging sequences had been tested to produce the best signal to noise ratio
(SNR) in phantom studies and was applied in rat kidney studies to measure the cellular
injury after ischemia [6]. In addition, two techniques were devised to further improve the
SNR in TQF imaging. The first was called weighted signal submission, which works by
collecting maximum signal averages when the phase-encoding gradient is minimum and
reducing the number of signal averages as the gradient amplitude increases. This
technique can improve the SNR by 50%. The second technique is called coherent
summation of multiple echoes. With this method, a multi-echo data set is collected using
repeated reversal of the read-out gradient. The alternate echoes in the multi-echo data set
are reversed and then all the echoes are added together, which was proved to result in ~
60% increase in SNR.
2.7 31P MR Spectroscopy in liver
With a 100% natural abundance and being the third most sensitivity relative to 1H, 31P is
the most widely used nucleus to study in vivo metabolic process and energetic status, for
phosphorus metabolites play a key role in metabolic reactions involving energy
production and transfer. These metabolites are also used to regulate and fine tune many
9metabolic pathways. Because liver is an organ with a robust role in metabolism, 31P MR
could be an optimal tool to noninvasively monitor and study the metabolism and
energetics in liver.
The typical 31P spectrum of rat liver is shown in Figure 3. The resonance for
phosphomonoesters (PME) contains contributions from a number of small molecular
weight phosphorylated intermediates, like phosphocholine (PC), phosphoethanolamine
(PE), adenosine monophosphate (AMP), and glycolytic intermediates. Elevated level of
PME signal usually implies biosynthesis of phospholipid and membrane remodeling,
which could happen in some disease states, like liver cirrhosis and tumors [34]. The
resonance of PDE mainly contains contributions from glycerophosphorylacholine (GPC)
and glycerophosphorylethanolamine (GPE), which are produced by sequential hydrolysis
of phospholipids by phospholipases A1 and A2, and represents membrane degradation.
Because PME and PDE usually develop in opposite direction, the ratio of PME and PDE
is often calculated as robust marker for membrane metabolism. High levels of PME/PDE
have been reported in hepatic tumors and in regenerating lives following hepatic
resection [34].
Inorganic phosphate (Pi) is produced by a number of phosphoesterases, and plays a major
role in ATP synthesis, either in oxidative pathway or in glycolytic pathway. The Pi
resonance could be used to measure intracellular pH, because the chemical shift of Pi,
relative to the –ATP signal, is sensitive to pH changes. pH is calculated using the
Henderson-Hasselbach equation, as followed:

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

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
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
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25.13
85.10
log76.6 ,
Where  is the chemical shift in ppm for Pi resonance signal.
-, - and -ATPs are energy rich compounds. –phosphate is the primary phosphate of
nucleoside tri- and di-phosphates. –phosphate is the terminal phosphate of nucleotide
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tri- and di-phosphates. β–phosphate is the middle phosphate of nucleoside triphosphates
only. 31P MRS can detect these compounds at a concentration above 1 mM. In normal
condition, those energetic compounds are maintained in a relatively constant level
through homeostatic process, however, in pathological states, like cancers, the levels of
those compounds could be changed [27, 35].
Figure 3. In vivo 31P MR spectrum of rat liver showing resonances (from left to right)
from PME, PDE, Pi, and three phosphate groups of ATP molecule; -ATP, -ATP and
–ATP.
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CHAPTER 3
METHODS
3.1 Acute and chronic CCl4 liver injury animal models
Acute CCl4-induced hepatotoxic experiments were performed on two groups of male
Wistar rats (200 - 300 g, n = 8 in each group), shown in Table 1; the rats in CCl4 group
were given a single oral dose of 5 ml/kg body weight (BW) of a CCl4 and corn oil
mixture (ratio 1:1), and the rats in the control group received a single dose of 5 ml/kg BW
of corn oil. SQ and TQF 23Na MRI experiments were performed on the CCl4 group
before and 24 hr after the treatment. SR-aided 23Na and 31P MRS experiments were
performed on the control and CCl4 groups 24 hr after the treatment.
For chronic CCl4-induced hepatotoxic experiments two groups of Wistar rats (70 - 80 g,
n= 7 in each group) were studied, shown in Table 1. The rats in CCl4 group initially
underwent Phenobarbital (0.35 ml per liter of drinking water) treatment for two weeks.
Subsequently, 1 ml/kg BW of a CCl4 and corn oil mixture (ratio 1:1) were given orally
twice per week for eight weeks. The rats in control group underwent the same treatment
as the CCl4 group except that only 1 ml/kg BW of oil was given orally. Phenobarbital
water treatment went throughout the total 10 weeks. The animal weights were recorded
before each oral treatment. SQ and TQF 23Na MRI experiments were performed on both
the groups before and on weeks 2, 4, 6 and 8 after initiating the CCl4 treatment. SR-aided
23Na and 31P MRS experiments were performed on all the rats on week 8 after the last
23Na MRI experiment.
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Table 1. Animal grouping in acute and chronic CCl4-induced hepatotoxic experiments
on rats.
Note: Acute intoxication was induced by CCl4 in a dose of 2.5ml/kg BW and duration of
24 hours. Chronic intoxication was induced by CCl4 in a bi-weekly dose of 0.5ml/kg BW
and duration of 8 weeks.
3.2 SQ and MQF 23Na MRI
All in vivo MR experiments were performed with a Varian 9.4 Tesla 31-cm diameter
actively shielded horizontal bore MR system. The system is equipped with a 12 cm
diameter gradient insert capable of generating 38 gauss/cm gradient strength in all three
directions.
A 50 mm diameter and 30 mm high loop-gap resonator tuned to 106 MHz was used for
SQ and TQF 23Na MRI experiments. A 10 mm NMR tube filled with 50 mM NaCl
solution was placed beside the internal wall of the coil to serve as a 23Na MRI signal
intensity standard. The rats were anesthetized with 1-2% isofluorane in medical air at a
flow rate of 2 ml/min for SQ and TQF 23Na MRI experiments. Warm air was blown
through the magnet bore to maintain the animal core body temperature at 34-35 °C,
which was monitored with a fiber optic probe (FISO Technologies Inc., Quebec,
Canada). The magnet was shimmed to less than 100 Hz line-width at half-height of the
23Na signal.
Dose CCl4 Oil n
Acute –24 hours
Control Single - 5.0 ml/kg 8
Treated Single 2.5 ml/kg 2.5 ml/kg 8
Chronic –8 weeks
Control Twice Weekly - 1 ml/kg 7
Treated Twice Weekly 0.5 ml/kg 0.5 ml/kg 7
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SQ 23Na MR images of the abdomen were obtained using a three-dimensional (3D)
gradient-echo imaging sequence and the following imaging parameters: 100-130 µs 90°
excitation RF pulse, 50 ms repetition-time (TR), 4.5 ms echo-time (TE), and 64  64  16
data points over a 60  60  60 mm field of view (FOV). The weighted signal summation
(WSS) technique was employed in the two phase-encoding directions to improve SNR. A
maximum of 64 and an average of 9.67 signal transients were collected for the phase-
encoding steps. Total data collection time for the 3D 23Na image was 10 minutes.
TQF 23Na MR images of the tumor were obtained using the pulse sequence shown in
Figure 4. This sequence is essentially a concatenation of a three-pulse TQ filter with a 3D
gradient-echo imaging sequence. This imaging sequence produces the optimum SNR and
fewest image artifacts compared to the TQF imaging sequences in which the phase-
encoding gradients are applied during the preparation time or evolution time. The other
imaging parameters were: 100-130 µs 90°RF pulses, 100 ms TR, 4.5 m TE, and 64  32
 8 data points over a 60  60  60 mm FOV. An optimum preparation time of 4.5 ms,
which gives maximum SNR, was used. The evolution time was kept as short as possible
(10 µs) to reduce signal loss due to TQ T2 but allow RF phase switching. The WSS
technique with a maximum of 384 and an average of 109.22 signal averages was
employed to increase SNR. The number of acquisitions was increased in steps of 6 to
complete the basic phase-cycle necessary for selecting a TQ coherence. Total data
collection time for TQF 23Na MRI was 55 minutes.
Figure 4. Gradient echo imaging sequence for TQF 23Na MRI. The readout dephasing
gradient (Gro) and phase-encoding gradient (Gpe) are applied after all the RF pulses, and
a gradient echo is formed along the readout direction.
90 o 90 o90 o180 o
RF
Gro
Gpe
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SQ and TQF 23Na MRI time-domain data were zero-filled to 128  128  16 and Fourier-
transformed. ROI were drawn outlining the liver region, and the signal intensities of SQ
and TQF 23Na MRI were calculated as the ratios to that of 50 mM NaCl solution
reference.
3.3 SR-Aided 23Na and 31P MRS
A 2 cm diameter surface coil dual-tuned to 106 and 163 MHz was used for SR-aided 23Na
and 31P MRS experiments. A small glass bulb (~300 µL) containing 150 mM NaCl and
20 mM TmDOTP5- at pH 5.0 was placed in a holder in the center of the surface coil and
used as an external concentration standard. This solution provided external reference
signals for both the 23Na and 31P spectra. The 23Na signal shifted by ~10 ppm was used as
the reference for tissue 23Na signal. The 31P signal from the four equivalent phosphonate
groups of TmDOTP5-, shifted to -315 ppm (by lowering the pH), was used as a reference
for the tissue TmDOTP5- signal at about -330 ppm. The nominal 90 excitation pulse-
width at the coil center was 55 µs for 23Na and 50 µs for 31P during the calibration and
the in vivo experiments.
The 23Na and 31P signals from the reference bulb were calibrated before the in vivo
experiments using ~60 ml volume plastic bags filled with NaCl and TmDOTP5-solutions.
Seven bags filled with 10-70 mM NaCl were used for calibration of the 23Na signal, and
13 bags filled with 0.2 to 3.0 mM TmDOTP5- were used to calibrate the 31P signal. Eight
of the TmDOTP5- bags were filled with 60 mM NaCl, and the other eight were filled with
150 mM NaCl to examine the effects of coil loading the calibration. The bags were
positioned under the dual-tuned surface coil, and 23Na or 31P spectra were collected and
processed by using the same parameters as in the in vivo experiments. The ratio of the
peak areas from either Na+ or TmDOTP5- in the bags, relative to the corresponding
reference in the bulb vs. the known concentration of Na+ or TmDOTP5- in the bag is
shown in Figure 5. A least squares linear regression of the data yielded calibration slopes
of 0.0288 ±0.0010, respectively, for 23Na (r2 = 0.99) and slope and intercept of 0.984 ±
0.021 and -0.194 ±0.028, respectively, for 31P (r2 = 0.98).
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Figure 5. Calibration curves for 23Na and 31P spectroscopy; (a) integrated areas of Na+ in
sealed bags at serial concentrations vs. 150 mM Na+ from a reference tube. (b) integrated
areas of TmDOTP5- in sealed bags at serial concentrations vs. 20 mM TmDOTP5- from
the reference tube.
The rats were surgically prepared for SR infusion and for placement of the dual-tuned
surface coil on the liver. After assuring adequate depth of anesthesia with isofluorane, a
jugular vein was cannulated through a midline neck incision for infusion of the SR. A
nephrorectomy was performed to prevent the clearance of TmDOTP5+ through the
kidneys. A laparotomy was performed, and the liver was exposed through a subcostal
incision. The liver was covered with a single layer of Saran wrap and the surface coil was
placed over the liver. Animals were positioned supine in a specially constructed cradle
and poisoned inside the magnet. The animal core body temperature was maintained at 34-
35 °C by blowing warm air through the magnet bore.
The surface coil was initially tuned to the 23Na frequency and the magnet was shimmed
to 60-70 Hz line-width at half-height of the 23Na signal. The coil was then tuned to 31P
frequency, and then, a set of baseline 31P tissue metabolite and TmDOTP5- spectra was
collected before SR infusion. The coil was re-tuned to 23Na frequency and 23Na spectra
were continuously collected during SR infusion. An 80 mM Na4HTmDOTP
(Macrocyclics, Dallas, TX) stock solution, prepared in deionized water, was initially
infused at a rate of 0.03 ml/min for 6 min. The rate was increased to 0.06 ml/min for 6
min, and then to 0.1 ml/min for another 6 min. After that the rate was maintained at 1.3
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ml/min for 20-30 min. After a chemical shift separation of 3-4 ppm was achieved
between the intra- and extracellular Na+ resonances, the infusion rate was reduced to
0.03-0.04 ml/min for 10-15 minutes to attain a stable shift of extracellular Na+ resonance.
In vivo 23Na and 31P from the rat liver were collected using a pulse-acquire sequence.
23Na spectra were collected using a 100 ms pre-delay, 2,000 data points (real + imaginary)
over a spectral width of 10,000 Hz, and 128 signal averages over ~40 s. 31P spectra of the
liver phosphorus metabolites and TmDOTP5- were collected separately because the
phosphonate group of TmDOTP5- resonate -300 ppm away from the tissue metabolite
signals. 31P metabolite spectra were collected using a pre-delay of 1 s, 4,000 data points
over a spectral width of 8,000 Hz, and 256 signal averages over ~290 s. 31P spectra of
TmDOTP5- were collected using a pre-delay of 10 ms, 2,000 data points over 20,000 Hz
spectral width, and 1024 signal transients over 62 s. All time domain data were Fourier
transformed after baseline correction, zero-filling once, and multiplication by a single
exponential corresponding to a 10-Hz line broadening for 23Na, a 25-Hz line broadening
for 31P metabolites, and a 100-Hz line broadening for TmDOTP5-. The peak areas were
determined by integration between user defined intervals. Peak area ratios between the
tissue and the corresponding reference bulb signals were then calculated, and tissue
concentrations were determined from the 23Na and 31P reference calibration curves as
described below. The results from three consecutive steady-state spectra were averaged.
The concentration of TmDOTP5- in tissue, [TmDOTP5-]tissue, was determined from the
peak areas of the 31P TmDOTP5- resonance from the tissue ( TmtissueA ), the reference bulb
( TmrefA ) and the reference calibration constants by using the following equation,

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The concentration of TmDOTP5- in extracellular space, ([TmDOTP5-]ext) was determined
from the chemical shift separation (in ppm) between Nae+ and Nai+ resonances in the in
vivo 23Na spectra by using the following equantion,
17
)4.0(
06.1
1][ 5 
ie NaNaext
TmDOTP 
The relative extracellular space (rECS) was calculated by using the relation,
ext
tissue
TmDOTP
TmDOTP
rECS
][
][
5
5



The relative intracellular space was calculated from the rECS and rDW by using the
relation,
rDWrECSrICS  1
The sodium concentration in cellular water ([Na+]i) was calculated from the peak areas of
the Nai+ ( TmtissueA ), reference resonances in
23Na spectra, the reference calibration constants,
and the rICS by using the following equation,
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After the ATP peak collection, the coil was tuned back to 23Na and power arrayed for
finding the best 90ºpulse for 23Na spectroscopy.
3.4 Histological examination
After the SR-aided MRS experiments, rats were sacrificed. Livers were excised, and one
lobe of liver tissue was fixed in zinc-formalin solution (Anatech, Battle Creek,, MI) and
embedded in paraffin. Liver tissue slices sectioned ~ 5 µm thicknesses were stained with
hematoxylin and eosin (H&E). Digital microscopic images of the liver sections were
taken in 100×and 400×magnification. Another lobe of liver was weighted and dried to
measure the ratio of wet tissue to dried tissue.
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CHAPTER 4
RESULTS
4.1 Effect of CCl4 on animal body weight
In acute intoxication experiment, 24 hours after the high dose CCl4 treatment, the average
animal weight decreased by 7% (from 241±23 to 224±22 g, P<0.0005). In chronic
intoxication experiment, before starting the oil or CCl4 treatment, the average body
weight of control or experimental rats was ~170g around 6-week old, then, through the
eight-week study, the CCl4-treated rats showed an retarded growth and the body weight
was less than that of control rats of the same age (333±7 and 371±2 g, respectively, at
week 8, P<0.001), shown in Figure 6.
Figure 6. Effect of CCl4 treatment on rat weight. The average weight of CCl4 treated
rats was less than that of control rats of the same age. (P< 0.05, * - vs. control of the same
age)
4.2 In vivo SQ and TQF 23Na MR imaging experiments
Figure 7 shows the representative transaxial slices from 3D SQ and TQF 23Na MR
images of the rat liver before and 24 hours after the high dose CCl4 treatment. The
increase of 23Na signal intensity both in SQ and TQF MRI can be clearly seen as changes
in color from green to red. Reference tube with 50 mM NaCl appeared in the SQ 23Na
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MRI but not in the TQF 23Na MR images, which proved the effective filtering of SQ 23Na
signal in TQF 23Na MRI. Region of interest (ROI) was drawn in white circle to cover
the liver without including the kidney and vasculature. The increase in 23Na signal
intensity of ROIs in SQ and TQF MRI display a remarkable increase. The SQ 23Na SI of
rat liver, relative to the reference, increased from 0.60±0.03 to 1.10±0.02 (P<0.05) and
TQF 23Na SI increased from 0.35±0.11 to 0.96±0.12 (P<0.05), before and 24 hours after
CCl4 treatment, shown in Figure 8.
Figure 7. Representative slices from a 3D SQ (a, b) and TQF (c, d) 23Na MRI of rat liver
before (a, c) and after (b, d) acute CCl4 intoxication (5ml/kg bw of mixture of CCl4 and
oil in 1:1 ratio). The region of liver was marked by white line.
Figure 8. Effects of high-dose acute CCl4 intoxication on SQ and TQF 23Na SI of rat
liver. The 23Na SI in SQ and TQF MRI increased by 80% and 90% respectively, 24
hours after the treatment, compared with baseline data.(from 0.6±0.03 to 1.1±0.02;
0.35±0.11 to 0.96±0.12, *P<0.05)
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In chronic CCl4 intoxication experiment, the representative transaxial slices from 3D SQ
and TQF 23Na MR images of the rat livers through week 0 to week 8 were shown in
Figure 9. ROIs of rat liver were circled in white line. The graph of 23Na SI through 8-
week experiment, relative to reference, is shown in figure 10. For SQ MRI, in CCl4
treatment group, the average 23Na SI were 0.69±0.03 before CCl4 treatment. Along with
the CCl4 treatment, the SI remained relatively constant from week 1 to week 6 but
afterwards increased significantly from 0.70±0.01 to 0.87±0.03 (P<0.05) from week 7 to
week 8, while in the control group, the SI changed in a downshift trend, decreasing
continuously from 0.77±0.05 before oil treatment to 0.51±0.02 at week 8 (P<0.05). For
TQF MRI in CCl4 group (Figure 11), the average SI was 0.32±0.03 before CCl4 treatment,
then steadily increased by 64% over the 8-week period, from 0.40±0.02 at week 2,
0.42±0.02 at week 4, 0.46±0.02 at week 6 to 0.52±0.02 at week 8. The statistically
significant increase happened from week 1 to week 2 and from week 6 to week 8, while
the SI increases from week 2 to week 4 and from week 4 to week 6 were not significant
statistically. In control rats, the overall change of SI through 8 weeks showed a
downshift trend, from 0.37±0.08 at week 0 to 0.23±0.02 at week 8 (P<0.05).
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Figure 9. Representative slices from a 3D SQ and TQF 23Na MRI of rat liver during 8-
week study. The liver regions were marked by white line. SQ and TQF 23Na SI of rat
liver in CCl4 treated rats increased continuously shown in color change.
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Figure 10. Effect of chronic low dose CCl4 intoxication on SQ 23Na SI. The SI of
control and treated rats was ~0.7 with no significant difference, then following the
treatment, SI of CCl4-treated rat was much higher than control at every time point, and
also had a sharp increase by 25% from week 6 to week 8. (P< 0.05, * - vs. control, # - vs.
previous time point, ‡- vs. week 0)
Figure 11. Effect of chronic low dose CCl4 intoxication on TQF 23Na SI. The SI of
control and treated rats were ~0.35 with no significant difference, then following the
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treatment, SI of CCl4-treated kept increasing and was much higher than those of control
at every time point. At week 8, SI of CCl4 treated rats was 135% higher than control. (P<
0.05, * - vs. control, # - vs. previous time point, ‡- vs. week 0)
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4.2 In vivo SR-aid 23Na and 31P spectroscopy
Representative in vivo 23Na and 31P spectra of control rat liver before and after infusion of
TmDOTP5- are shown in Figure 12. Before infusion of SR, the intra and extracellular
Na+ resonance peaks were isochronous (set to 0 ppm). After infusion of SR, the
extracellular Na+ resonance peak shifted about 5 ppm downfield, while the intracellular
Na+ resonance remained at 0 ppm. The 23Na resonance peak at 12 ppm originated from
Na+ in the reference bulb. In 31P spectra, the two peaks at ~315 ppm were from the
TmDOTP5- in the same reference bulb. The peak at ~325 ppm was from the SR in the rat
liver after infusion of TmDOTP5- and is closely related to the size of the rECS. In 31P-
metabolites spectra, the three phosphate groups in ATP molecule gave three separated
peaks, and the areas under curve of the ATP peaks were no significant difference (P<
0.05) before and after infusion of TmDOTP5-. The PCr peak of phosphocreatine was
from the muscle of neighboring tissues, like diaphragm, abdominal wall or intestine, and
was kept small by a careful placement of the surface coil to obtain minimal touching with
those tissues. The peak of organic phosphate (Pi) and the peak of phosphomonoesters
(PME) were also acquired from the liver tissue.
Figure 13 shows the typical 23Na and 31P spectra of rat livers in acute and chronic CCl4
experiments. Compared to the 23Na spectra in control rats, the intracellular Na+ peak in
acute CCl4 treated rats and the extracellular Na+ peak in chronic CCl4 treated rats became
significantly enlarged. Also, the 31P-SR peak in chronic CCl4 group is shown to be
obviously higher than that in control group, which implies enlarged rECS. There is not
remarkable difference in APT specs between control rats and CCl4 treated rats.
The quantitative data acquired by 23Na and 31P MRS are summarized in Table 2 and 3. In
acute CCl4 experiment, the values of rECS, rICS, and rDW do not show much difference
between control rats and CCl4-treated rats, however, for [Na+i], there is significant
increase from 17  2 to 49  7 (P<0.01), and also for [Na+t], from 322 to 464 (P<0.01).
The ATP/Pi ratio, which stands for cellular energetics, had a significant decrease between
1.240.08 and 0.940.10 (P<0.05) in control and CCl4 treated rats, respectively.
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In chronic CCl4 experiment, the rDW of liver shows a significant decrease between CCl4
treated rats and control rats (0.220.01 and 0.280.11, P<0.05). The rECS was
significantly higher in CCl4-intoxicated rats (0.280.03) than in controls (0.190.03;
P<0.05), and [Na+t] was significantly higher in the CCl4-treated rats (527) than in the
controls (354, P<0.05). There is no significant change in [Na+i] between two groups.
For cellular energetics and pH, there is also no significant change between two groups.
In summary, compared to control rats, acute CCl4 treatment caused a significant
increased in [Na+i] and [Na+t], and chronic CCl4 treatment caused a significant increase in
rECS and [Na+t].
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Figure 12. Representative in vivo 23Na and 31P spectra of control rat before and after
infusion of SR. Na+e resonance shifted away from Nai about 4 ppm and TmDOTP5-
resonance from liver tissue appeared about 12 ppm away from reference after infusion of
SR. 31P metabolites resonances are not different before and after infusion of SR.
Figure 13. Representative 23Na and 31P spectra of rat liver after infusion of SR in acute
CCl4 treated rats and chronic CCl4 treated rat at week 8. Nai resonance grew much larger
in acute CCl4 intoxication while Nae resonance grew much larger in chronic CCl4
intoxication, compared to reference. SR resonance from liver tissue also grew much
larger compared to SR reference in chronic CCl4 intoxication.
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Table 2. Comparison of parameters of liver tissue by 23Na and 31P spectroscopy between
control and CCl4 treated rats in high dose acute experiment. (* - P<0.05)
Table 3. Comparison of parameters of liver tissue measured by 23Na and 31P
spectroscopy between control and CCl4-treated rats in low dose chronic experiment. (* -
P<0.05)
Control CCl4 P-values
rDW 0.27 ±0.01 0.27 ±0.01 0.72
rECS 0.24 ±0.02 0.26 ±0.01 0.22
rICS 0.49 ±0.02 0.47 ±0.02 0.35
[Na+t], mM 32 ±2 46 ±4 * 0.005
[Na+i], mM 17 ±2 49 ±7 * 0.0005
ATP/Pi 1.24 ±0.08 0.94 ±0.10 * 0.012
pH 7.33 ±0.02 7.29 ±0.01 0.66
[Mg2+free] 563 ±26 540 ±37 0.63
Control CCl4 P-values
rDW 0.28 ±0.01 0.22 ±0.01 * < 0.0001
rECS 0.19 ±0.03 0.28 ±0.03 * 0.03
rICS 0.53 ±0.03 0.50 ±0.03 0.35
[Na+t], mM 35 ±4 52 ±7 * 0.04
[Na+i], mM 18 ±2 18 ±2 0.93
ATP/Pi 1.24 ±0.12 1.35 ±0.07 0.59
pH 7.36 ±0.04 7.29 ±0.03 0.28
[Mg2+free] 661 ±43 572 ±41 0.27
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4.3 Liver histology
The light microscopic images of rat liver slices of control and CCl4 treated rats by H&E
staining were shown in Figure 14. In acute experiment, 24 hours after high dose CCl4
treatment, acute inflammatory response was shown mainly in the centrilobular regions,
like neutrophils infiltration, significant fatty infiltration in hepatocytes and hepatocellular
necrosis with swollen cells and dissolved nucleus.
In chronic experiment, 8 weeks after low dose CCl4 treatment, there were abundant and
extensive collagen bundles in liver parenchyma and mild fatty infiltration in hepatocytes.
Figure 14. Histological examination of rat liver slices by H& E staining in 100×(up row)
and 400×(down row) magnification. (a,b) Slices of normal control rat liver. (c,d) acute
CCl4 induced liver injury, shown with inflammatory response in centrilobular regions,
like fatty deposition, neutrophils infiltration and hepatocellular necrosis. (e,f) chronic
CCl4 induced liver injury, shown with abundant collagen bundles.
a
b
c
d
e
f
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CHAPTER 5
DISCUSSION
To be able to noninvasively detect and monitor the extent and progression of liver disease,
especially the chronic liver disease, is a major priority in clinical area. A variety of
diagnostic modalities such as laboratory liver function tests, ultrasonography,
computerized tomography (CT) and MRI, have been proposed to try to accomplish this
aim and yet remain under extensive evaluation [4, 11, 36-40]. Laboratory tests, including
measurements of aspartate aminotransferase (AST) to alanine aminotransferase (ALT)
ratio, AST to platelet ratio index (APRI), or FibroTest, a composite of five serum
biochemical markers of -2-macroglobulin, apolipoprotein A1, haptoglobin, -
glutamyltranspeptidase, and bilirubin, are closely related to hepatocellular function.
However, all of the serum based tests have their cited variation in specificity and
sensitivity [38]. For example, AST/ALT test has been found to be not very specific due
to the enzymatic sources outside of liver. FibroTest is only useful in diagnosing
significant fibrosis and cirrhosis, and suffers from poor sensitivity for mild liver disease,
such as early to intermediate fibrosis and steatosis [38]. The noninvasive imaging
modalities, including ultrasonography, MRI or contrast-enhanced MRI, and CT, are more
related to the gross morphologic or physical features of liver, like stiffness, shape or
anatomic relationship to neighboring organs. Thus, their specialties are more targeted on
assessment of well-developed liver fibrosis and have limited diagnostic utility in
monitoring the whole progression of liver disease, especially in detection of liver disease
at its early stage and diffuse liver disease [38, 41].
Based on the knowledge that sodium ions play an important role in normal hepatocelluar
activities and the ionic homeostasis could be disrupted due to the compromised cellular
integrity and energy status in disease states, the current study evaluated the performance
of SQ and TQF 23Na MRI technique in monitoring the severity and progression of the rat
liver injury in CCl4 induced hepatotoxic model. In addition, SR-aided 23Na and 31P MRS
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was employed in the same model to validate and find the mechanisms behind the changes
in 23Na MRI SI following CCl4 intoxication treatment.
The data presented in this study shows that, in acute high dose CCl4 intoxication
experiment, 24 hours after CCl4 treatment, the SQ 23Na SI of rat liver increased by 80%
and TQF 23Na SI increased by 70%, compared with the baseline data before treatment.
The pronounced increase in SQ 23Na SI is similar to the results from other studies [42,
43], which used 1H and 23Na MRI to measure the CCl4-induced liver tissue damage.
According to those studies, the SIs of liver both in 1H and 23Na MRI increased, and it was
thought that a build-up of both water and sodium ion in hepatocytes was the reason
behind the increase as a result of cytotoxic edema. In current study, the subsequent SR-
aided 23Na and 31P MRS experiment found that [Na+i] of liver tissue in CCl4-treated rat
increased by 174%, compared to baseline data. The histological examination showed
widespread swollen hepatocytes in centrilobular regions. CCl4 could damage the cell
membrane through lipid peroxidation mechanism and increase its permeability to
extracellular ions, including Na+, with results of elevated [Na+i] and hepatocellular water
retention [44]. Furthermore, in SR-aided MRS, it was found that the cellular energetic
status, as measured by ATP/Pi ratio, was significantly decreased 24 hours after the CCl4
treatment, which suggested that the [Na+i] could also be increased due to reduced activity
of Na+/K+ pump for shortage of ATP supply. In TQF 23Na MRI, the considerable
increase of 23Na SI was the direct result of the large increase in [Na+i]. Actually, the
percentages of increase, in 23Na SI measured by TQF 23Na MRI and [Na+i] measured by
SR-aid 23Na MRS, were almost the same, to be 180% and 174% respectively.
In chronic CCl4 intoxication experiment, the results display a different scenario compared
with those in the acute experiment. SQ 23Na SI of CCl4 treated rat liver first remained
relative constant up to 6 weeks from start, but it was significantly higher than that in
control rats. Then, the SI increased by 15% from week 7 to week 8. In TQ 23Na MRI, the
value of SI went up all the way from start, especially during two periods, that is, by 18%
increase from week 0 to week 2 and 16 % increase from week 6 to week 8, while the SI
in control rats kept significantly much lower. In SR-aided MRS, in CCl4 treated rats, the
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measured [Na+t] and rECS increased by ~49% and ~48%, compared to those in control
group at week 8. As a number of researches had found that, in chronic liver disease,
there exists a mixed process of liver damage and recovery [19, 23, 45]. The early
significant increase in SQ 23Na SI, compared to control, could be due to the initial injury
from week 1 to week 2, which reversed the down shifting trend of SI in control rats.
Then afterwards, from week 3 to week 6, the recovery process began to develop and
compensate for the disrupted hepatic functions, e.g., to maintain the homeostasis of water
and salts content in liver tissue. This process might explain the relatively constant level
of SQ 23Na SI from week 3 to week 6. However, after week 6, the compensatory
mechanism began to collapse in the face of persistent CCl4-induce damage. Thus,
accelerated retention of water and salts in liver occurred, resulting to significant increase
in SQ 23Na SI. This process was consistent with the findings in a variety of studies,
which discovered that moderate or advanced liver fibrosis started around or after 6 weeks
in long term CCl4-induced experiment [19, 24, 39].
As for TQF MRI, 23Na SI displayed an ever-increasing trend. There are two possible
explanations behind this trend; one could be due to the continual increase in [Na+i] and
the other could be due to the continual built-up of extracellular protein matrix, and the
later can also increase the rECS. Taking into account of the data from 23Na and 31P MRS,
which demonstrated that rECS was increased by ~48% at week 8 compared to control
rats; therefore, the abundant deposition of extracellular matrix protein could be a main
reason behind the increased TQF 23Na SI. This conclusion was in accordance with the
histology study and also with the finding of some studies [24, 46], that liver fibrosis
began to take a full-fledged role in pathologic changes after week 6, like overproduction
of collagen fibers and accumulation of extracellular matrix. This finding can explain why
there was a steeper increase in TQF 23Na SI from week 7 to week 8. As for the role of
Na+i, because there was no significant difference in [Na+i] between control and CCl4
treated rats at week 8, the sharp increase in TQF 23Na SI might be not closely related to
the changes in [Na+i].
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Overall, SQ and TQF 23Na MRI appears valuable in the functional assessment of the liver
in a noninvasive approach. The present research represents the first application of both
SQ and TQF 23Na MRI technique in monitoring the acute and chronic liver injury in
CCl4-induced rat model. Furthermore, compared to SQ 23Na MRI, the TQF 23Na MRI
technique might be more sensitive in monitoring the progression of chronic liver damage
in that the contrast in TQF 23Na SI between treated rats and control rats is much higher
than that in SQ 23Na SI. 23Na and 31P MRS study was also the first application in this
model for validation of the results of 23Na MRI. In conclusion, with proven sensitivity
and specificity, SQ and TQF 23Na MRI could be promising diagnostic modality for liver
diseases in clinical area.
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